Downloadable Documents

To avoid delays, please fill out the entire form

A prospective, blinded, observational, multicenter, international study designed to evaluate three different RNA signatures related to rejection and injury of transplanted kidneys.

Tutivia® is a blood-based proactive risk assessment tool for acute rejection in your kidney transplant patients. Tutivia® uses RNA sequencing technology that helps answer your questions to deliver a more patient-centric care plan.

Contents & Instructions

Performance of Next-Gen Sequencing Biomarker Tutivia® in Setting of Kidney Delayed Graft Function

Verici Dx Drives Innovation with Next-Generation Sequencing for Kidney Transplant Prognosis Using Illumina Connected Analytics on AWS.